THE UNDISPUTED, BEST IN CLASS CENTRAL LINE INTRODUCER

The unique, valved introducer sheath of the CVC WAND is designed to prevent air embolism (a NEVER EVENT) and CLABSIs, while also creating a virtually bloodless procedure.

The novel design of the CVC WAND helps prevent the risks of central line insertion that have been associated with existing technology. It is the first and only safety introducer of its kind to provide valuable benefits for hospitals, practitioners and most importantly, patients.

A FASTER AND SAFER WAY TO INTRODUCE CENTRAL LINES

unrivaled performance

What potential benefits differentiate the design of CVC WAND from existing technologies?

Reduced risk of external surface contamination of the inserted catheter

Reduced risk of guidewire induced arrhythmia (CVC WAND AST)

Reduced risk of guidewire embolism (CVC WAND AST)

Reduced risk of air embolism

Virtually bloodless

CVC WAND vs Competitors

airguard+

flowguard+

CVC WAND++

Air Leakage

0.15 cc/sec

4.0 cc/sec

0.0 cc/sec

+ At -12 mmHg vacuum pressure
++ At -55 mmHg vacuum pressure

PROVEN PATIENT SAFETY

The CVC WAND is designed to reduce the unnecessary risks inherent with current Seldinger technique insertion of central lines.

Catheter contamination/CLABSI risk:

During the most common procedure (seldinger technique) of CVC insertion, the catheter comes into direct contact with the skin as it enters into the vessel. These catheters have a 16.7% rate (5 in 30 patients) of bacterial surface contamination‡ which increases the risk of a CLABSI.

Air Embolism:

The CVC WAND offers the only air competent, peelable introducer sheath in the market. Since October 2008, CMC has deemed Intravascular Air Embolism a non-reimbursable event (a NEVER EVENT). The mortality rate from air embolism ranges from 23-50%‡.